Clavulanic acid stimulates sexual behaviour in male rats

European Journal of Pharmacology

Volumn 609, Issue 1-3, 2009, Pages 69-73

  Chan, Johnny S W ^a   Kim, Deog Joong ^b   Ahn, Chang Ho ^b   Oosting, Ronald S ^a   Olivier, Berend ^a,c,d  

^a UTRECHT UNIVERSITY   (Netherlands)

^b Rexahn Pharmaceuticals Inc   (United States)

^c PSYCHOGENICS INC   (United States)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

(Rat); Clavulanic acid; Ejaculation; Male sexual behaviour; Paroxetine; Pro sexual effect

Indexed keywords

CLAVULANIC ACID; PAROXETINE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; EJACULATION; FEMALE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SEXUAL BEHAVIOR;

ADMINISTRATION, ORAL; ANIMALS; CLAVULANIC ACIDS; DOSE-RESPONSE RELATIONSHIP, DRUG; EJACULATION; FEMALE; MALE; PAROXETINE; RANDOM ALLOCATION; RATS; RATS, WISTAR; REFERENCE STANDARDS; SEROTONIN UPTAKE INHIBITORS; SEXUAL BEHAVIOR, ANIMAL;

EID: 64549093699     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2009.03.009     Document Type: Article

References (17)

1. Ågmo A., and Ellingsen E. Relevance of non-human animal studies to the understanding of human sexuality. Scand. J. Psychol. 44 (2003) 293-301
2. Aversa A., Bruzzickes R., Pili M., and Spera G. Phosphodiesterase 5 inhibitors in the treatment of erectile dysfunction. Curr. Pharm. Des. 12 27 (2006) 3467-3484
3. Balon R. SSRI-associated sexual dysfunction. Am. J. Psychiatry 163 (2006) 1504-1509
4. Brown A.D., Blagg J., and Reynolds D.S. Designing drugs for the treatment of female sexual dysfunction. Drug Discov. Today 12 (2007) 757-766
5. Chan J.S.W., Olivier B., de Jong T.R., Snoeren E.M.S., Kooijman E., van Hasselt F.N., Limpens J.H.W., Kas M.J.H., Waldinger M.D., and Oosting R.S. Translational research into sexual disorders: pharmacology and genomics. Eur. J. Pharmacol. 585 (2008) 426-435
6. de Jong T.R., Pattij T., Veening J.G., Waldinger M.D., Cools A.R., and Olivier B. Effects of chronic selective serotonin reuptake inhibitors on 8-OH-DPAT-induced facilitation of ejaculation in rats: comparison of fluvoxamine and paroxetine. Psychopharmacology 179 (2005) 509-515
7. Giuliano F., and Allard J. Dopamine and male sexual function. Eur. Urol. 40 (2001) 601-608
8. Hull E.M., Muschamp J.W., and Sato S. Dopamine and serotonin: influences on male sexual behaviour. Physiol. Behav. 83 (2004) 291-307
9. Mos J., Mollet I., Tolboom J.T., Waldinger M.D., and Olivier B. A comparison of the effects of different serotonin reuptake blockers on sexual behaviour of the male rat. Eur. Neuropsychopharmacol. 9 (1999) 123-135
10. Nakagawa H., Yamada M., Tokiyoshi K., Miyawaki Y., and Kanayama T. Penetration of potassium clavulanic acid/ticarcillin sodium into cerebrospinal fluid in neurosurgical patients. Jpn. J. Antibiot. 47 (1994) 93-101
11. Nurnberg H.G., Hensley P.L., Heiman J.R., Croft H.A., Debattista C., and Paine S. Sildenafil treatment of women with antidepressant-associated sexual dysfunction. A randomized controlled trial. J.A.M.A. 300 (2008) 395-404
12. Olivier B., Chan J., Pattij T., de Jong T.R., Oosting R.S., Veening J., and Waldinger M.D. Psychopharmacology of male rat sexual behavior: modeling human sexual dysfunctions?. Int. J. Impot. Res. 18 Suppl 1 (2006) S14-S23
13. Pattij T., Olivier B., and Waldinger M.D. Animal models of ejaculatory behavior. Curr. Pharm. Des. 11 (2005) 4069-4077
14. Rosenzweig-Lipson S., Beyer C.E., Hughes Z.A., Khawaja X., Rajarao S.J., Malberg J.E., Rahman Z., Ring R.H., and Schechter L.E. Differentiating antidepressants of the future: efficacy and safety. Pharmacol. Ther. 113 (2007) 134-153
15. Rosen R.C., Lane R.M., and Menza M. Effects of SSRIs on sexual function: a critical review. J. Clin. Psychopharmacol. 19 1 (1999) 67-85 Review
16. Waldinger M.D., Zwinderman A.H., and Olivier B. SSRIs and ejaculation: a double-blind, randomized, fixed-dose study with paroxetine and citalopram. J. Clin. Psychopharmacol. 21 6 (2001) 556-560
17. Waldinger M.D., van de Plas A., Pattij T., van Oorschot R., Coolen L.M., Veening J., and Olivier B. The selective serotonin re-uptake inhibitors fluvoxamine and paroxetine differ in sexual inhibitory effects after chronic treatment. Psychopharmacology 160 (2002) 283-289